about
Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.GSK-3: Functional Insights from Cell Biology and Animal Models.Abnormalities in brain structure and behavior in GSK-3alpha mutant miceAdvancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.Assessment of social interaction behaviors.Crosstalk between metabolic and neuropsychiatric disordersPeptides targeting protein kinases: strategies and implications.Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders.Obesity and mental illness: implications for cognitive functioning.The putative impact of metabolic health on default mode network activity and functional connectivity in neuropsychiatric disorders.Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance.Neurological functions of the masterswitch protein kinase - gsk-3.Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.Alzheimer's disease in humans and other animals: A consequence of postreproductive life span and longevity rather than aging.Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.Glycogen Synthase Kinase-3 in Neurological DiseasesSelective loss of glycogen synthase kinase-3α in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation
P50
Q30408186-7ACD907D-064D-4AD4-94C2-B62249B58590Q30472813-A5F7AD0F-085B-43E6-95B1-D1669845055EQ30485018-21A49EAD-4583-4DD2-888F-EFD95D40A2F2Q30713152-06F80A8C-1902-43CA-BF7D-DA0343416A61Q35396257-8123BB74-8BBD-4A07-9D49-23B27F2E0694Q36073458-97F509F0-8452-44C1-9424-C295F1C809D3Q36659979-F830EFD2-3C34-467D-8A9B-FBA56F82A2F9Q36863419-1E690188-AD2F-40F5-ACA9-458F513F4E58Q38045690-A2926B44-6CB8-4D4B-B624-BF7981F32B28Q38120446-5D894089-CA34-4CED-A65A-C432E0E071F2Q38282332-B9A35C65-1107-4AA9-A39E-5DFABB781A66Q38320892-E63BC91D-9D2B-44E2-9F80-026AD52FADC2Q40509238-1591A4CA-D656-48F5-BB46-AAFDF5EC4180Q41772814-485F4FAF-8FAD-4844-BC91-0EFE8BD420C0Q42195030-E65B40F9-511E-43ED-909C-BC9D4ACFF4E0Q47860639-F4F3F4E2-3E4D-48B5-9764-586FC1540B3CQ51793426-1E988BC3-057F-4EDA-BF9A-76EEE11E26CCQ51803439-5EFB72A9-5BAF-4716-B0BC-FF4FBB666F3AQ57833123-DA3D371C-1E02-402F-A905-AD669C8AB2D1Q57833133-EC500E04-C50B-4E2D-A2BC-2CF70F6E1E50
P50
description
researcher ORCID ID = 0000-0002-5427-1151
@en
wetenschapper
@nl
name
Oksana Kaidanovich-Beilin
@ast
Oksana Kaidanovich-Beilin
@en
Oksana Kaidanovich-Beilin
@es
Oksana Kaidanovich-Beilin
@nl
type
label
Oksana Kaidanovich-Beilin
@ast
Oksana Kaidanovich-Beilin
@en
Oksana Kaidanovich-Beilin
@es
Oksana Kaidanovich-Beilin
@nl
prefLabel
Oksana Kaidanovich-Beilin
@ast
Oksana Kaidanovich-Beilin
@en
Oksana Kaidanovich-Beilin
@es
Oksana Kaidanovich-Beilin
@nl
P106
P1153
10143405000
P21
P31
P496
0000-0002-5427-1151